GSK says sells thrombosis brands, French plant (via AFP)
British drugs firm GlaxoSmithKline (GSK) said Monday that it has sold two thrombosis brands and a French plant to South African peer Aspen for £700 million ($1.13 billion, 834 million euros). “GSK today announced it has reached agreement to sell its…
